National Open University Library

Xenotransplantation and risk : (Record no. 12680)

MARC details
000 -LEADER
fixed length control field 02256cam a2200253 a 4500
INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9780521195768 (hardback)
INTERNATIONAL STANDARD BOOK NUMBER
ISBN 0521195764 (hardback)
DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 344.04/194
MAIN ENTRY--AUTHOR NAME
Personal name Fovargue, Sara,
TITLE STATEMENT
Title Xenotransplantation and risk :
Remainder of title regulating a developing biotechnology /
Statement of responsibility, etc Sara Fovargue
Copyright Date
Name of publisher CAMBRIDGE UNIVERSITY PRESS
Year of publication or production 2012
PHYSICAL DESCRIPTION
Number of Pages xiii, 291 p. ;
SERIES STATEMENT
Series statement Cambridge law, medicine and ethics
FORMATTED CONTENTS NOTE
Formatted contents note Machine generated contents note: 1. Introducing the issues; 2. Dealing with risk; 3. Regulating experimental procedures and medical research; 4. Regulatory responses to developing biotechnologies; 5. Challenges to legal and ethical norms: first party consent and third parties at risk; 6. Surveillance and monitoring: balancing public health and individual freedom; 7. Looking to the future
SUMMARY, ETC.
Summary, etc "Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health"--
SUBJECT ADDED ENTRY--TOPICAL TERM
Topical Term Xenografts
SUBJECT ADDED ENTRY--TOPICAL TERM
Topical Term Transplantation immunology
SUBJECT ADDED ENTRY--TOPICAL TERM
Topical Term Xenografts
SUBJECT ADDED ENTRY--TOPICAL TERM
Topical Term Transplantation of organs, tissues, etc
SUBJECT ADDED ENTRY--TOPICAL TERM
Topical Term Transplantation, Heterologous
SUBJECT ADDED ENTRY--TOPICAL TERM
Topical Term Transplantation, Heterologous
SUBJECT ADDED ENTRY--TOPICAL TERM
Topical Term Transplantation, Heterologous
ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Books
Holdings
Permanent Location Current Location Date acquired Full call number Accession Number Koha item type
Lagos Study Centre Lagos Study Centre 03/26/2024 QR188.8 .F68 2012 0028115 Books

Powered by Koha

//